Global Rheumatology Therapeutics Market Growth (Status and Outlook) 2024-2030

Product Code: 789971

Industry: Service & Software

Published: Jan 02,2024

Pages: 102

Delivery Time: 2-3 business days

Global Rheumatology Therapeutics Market Growth (Status and Outlook) 2024-2030

Product Code: 789971

Industry: Service & Software

Published: Jan 02,2024

Pages: 102

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to our LPI (LP Information) latest study, the global Rheumatology Therapeutics market size was valued at US$ 45350 million in 2023. With growing demand in downstream market, the Rheumatology Therapeutics is forecast to a readjusted size of US$ 53070 million by 2030 with a CAGR of 2.3% during review period. 
The research report highlights the growth potential of the global Rheumatology Therapeutics market.  Rheumatology Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rheumatology Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rheumatology Therapeutics market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:
The report on Rheumatology Therapeutics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Rheumatology Therapeutics market. It may include historical data, market segmentation by Type (e.g., Disease Modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rheumatology Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Rheumatology Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Rheumatology Therapeutics industry. This include advancements in Rheumatology Therapeutics technology, Rheumatology Therapeutics new entrants, Rheumatology Therapeutics new investment, and other innovations that are shaping the future of Rheumatology Therapeutics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rheumatology Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Rheumatology Therapeutics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rheumatology Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rheumatology Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rheumatology Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rheumatology Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rheumatology Therapeutics market.

Market Segmentation:
Rheumatology Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Rheumatology Therapeutics Market Size 2019-2030
        2.1.2 Rheumatology Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
    2.2 Rheumatology Therapeutics Segment by Type
        2.2.1 Disease Modifying Anti-rheumatic Drugs
        2.2.2 Nonsteroidal Anti-inflammatory Drugs
        2.2.3 Corticosteroids
        2.2.4 Uric Acid Drugs
        2.2.5 Others
    2.3 Rheumatology Therapeutics Market Size by Type
        2.3.1 Rheumatology Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
        2.3.2 Global Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    2.4 Rheumatology Therapeutics Segment by Application
        2.4.1 Hospital Pharmacy
        2.4.2 Retail Pharmacy
        2.4.3 Online Pharmacy
    2.5 Rheumatology Therapeutics Market Size by Application
        2.5.1 Rheumatology Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
        2.5.2 Global Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)

3 Rheumatology Therapeutics Market Size by Player
    3.1 Rheumatology Therapeutics Market Size Market Share by Players
        3.1.1 Global Rheumatology Therapeutics Revenue by Players (2019-2024)
        3.1.2 Global Rheumatology Therapeutics Revenue Market Share by Players (2019-2024)
    3.2 Global Rheumatology Therapeutics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Rheumatology Therapeutics by Regions
    4.1 Rheumatology Therapeutics Market Size by Regions (2019-2024)
    4.2 Americas Rheumatology Therapeutics Market Size Growth (2019-2024)
    4.3 APAC Rheumatology Therapeutics Market Size Growth (2019-2024)
    4.4 Europe Rheumatology Therapeutics Market Size Growth (2019-2024)
    4.5 Middle East & Africa Rheumatology Therapeutics Market Size Growth (2019-2024)

5 Americas
    5.1 Americas Rheumatology Therapeutics Market Size by Country (2019-2024)
    5.2 Americas Rheumatology Therapeutics Market Size by Type (2019-2024)
    5.3 Americas Rheumatology Therapeutics Market Size by Application (2019-2024)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Rheumatology Therapeutics Market Size by Region (2019-2024)
    6.2 APAC Rheumatology Therapeutics Market Size by Type (2019-2024)
    6.3 APAC Rheumatology Therapeutics Market Size by Application (2019-2024)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Rheumatology Therapeutics by Country (2019-2024)
    7.2 Europe Rheumatology Therapeutics Market Size by Type (2019-2024)
    7.3 Europe Rheumatology Therapeutics Market Size by Application (2019-2024)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Rheumatology Therapeutics by Region (2019-2024)
    8.2 Middle East & Africa Rheumatology Therapeutics Market Size by Type (2019-2024)
    8.3 Middle East & Africa Rheumatology Therapeutics Market Size by Application (2019-2024)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Rheumatology Therapeutics Market Forecast
    10.1 Global Rheumatology Therapeutics Forecast by Regions (2025-2030)
        10.1.1 Global Rheumatology Therapeutics Forecast by Regions (2025-2030)
        10.1.2 Americas Rheumatology Therapeutics Forecast
        10.1.3 APAC Rheumatology Therapeutics Forecast
        10.1.4 Europe Rheumatology Therapeutics Forecast
        10.1.5 Middle East & Africa Rheumatology Therapeutics Forecast
    10.2 Americas Rheumatology Therapeutics Forecast by Country (2025-2030)
        10.2.1 United States Rheumatology Therapeutics Market Forecast
        10.2.2 Canada Rheumatology Therapeutics Market Forecast
        10.2.3 Mexico Rheumatology Therapeutics Market Forecast
        10.2.4 Brazil Rheumatology Therapeutics Market Forecast
    10.3 APAC Rheumatology Therapeutics Forecast by Region (2025-2030)
        10.3.1 China Rheumatology Therapeutics Market Forecast
        10.3.2 Japan Rheumatology Therapeutics Market Forecast
        10.3.3 Korea Rheumatology Therapeutics Market Forecast
        10.3.4 Southeast Asia Rheumatology Therapeutics Market Forecast
        10.3.5 India Rheumatology Therapeutics Market Forecast
        10.3.6 Australia Rheumatology Therapeutics Market Forecast
    10.4 Europe Rheumatology Therapeutics Forecast by Country (2025-2030)
        10.4.1 Germany Rheumatology Therapeutics Market Forecast
        10.4.2 France Rheumatology Therapeutics Market Forecast
        10.4.3 UK Rheumatology Therapeutics Market Forecast
        10.4.4 Italy Rheumatology Therapeutics Market Forecast
        10.4.5 Russia Rheumatology Therapeutics Market Forecast
    10.5 Middle East & Africa Rheumatology Therapeutics Forecast by Region (2025-2030)
        10.5.1 Egypt Rheumatology Therapeutics Market Forecast
        10.5.2 South Africa Rheumatology Therapeutics Market Forecast
        10.5.3 Israel Rheumatology Therapeutics Market Forecast
        10.5.4 Turkey Rheumatology Therapeutics Market Forecast
        10.5.5 GCC Countries Rheumatology Therapeutics Market Forecast
    10.6 Global Rheumatology Therapeutics Forecast by Type (2025-2030)
    10.7 Global Rheumatology Therapeutics Forecast by Application (2025-2030)

11 Key Players Analysis
    11.1 Takeda Pharmaceutical
        11.1.1 Takeda Pharmaceutical Company Information
        11.1.2 Takeda Pharmaceutical Rheumatology Therapeutics Product Offered
        11.1.3 Takeda Pharmaceutical Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.1.4 Takeda Pharmaceutical Main Business Overview
        11.1.5 Takeda Pharmaceutical Latest Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Information
        11.2.2 Sanofi Rheumatology Therapeutics Product Offered
        11.2.3 Sanofi Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.2.4 Sanofi Main Business Overview
        11.2.5 Sanofi Latest Developments
    11.3 Genentech
        11.3.1 Genentech Company Information
        11.3.2 Genentech Rheumatology Therapeutics Product Offered
        11.3.3 Genentech Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.3.4 Genentech Main Business Overview
        11.3.5 Genentech Latest Developments
    11.4 Novartis
        11.4.1 Novartis Company Information
        11.4.2 Novartis Rheumatology Therapeutics Product Offered
        11.4.3 Novartis Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.4.4 Novartis Main Business Overview
        11.4.5 Novartis Latest Developments
    11.5 Janssen Biotech
        11.5.1 Janssen Biotech Company Information
        11.5.2 Janssen Biotech Rheumatology Therapeutics Product Offered
        11.5.3 Janssen Biotech Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.5.4 Janssen Biotech Main Business Overview
        11.5.5 Janssen Biotech Latest Developments
    11.6 Amgen
        11.6.1 Amgen Company Information
        11.6.2 Amgen Rheumatology Therapeutics Product Offered
        11.6.3 Amgen Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.6.4 Amgen Main Business Overview
        11.6.5 Amgen Latest Developments
    11.7 AbbVie
        11.7.1 AbbVie Company Information
        11.7.2 AbbVie Rheumatology Therapeutics Product Offered
        11.7.3 AbbVie Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.7.4 AbbVie Main Business Overview
        11.7.5 AbbVie Latest Developments
    11.8 Pfizer
        11.8.1 Pfizer Company Information
        11.8.2 Pfizer Rheumatology Therapeutics Product Offered
        11.8.3 Pfizer Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.8.4 Pfizer Main Business Overview
        11.8.5 Pfizer Latest Developments
    11.9 Bristol-Myers Squibb Company
        11.9.1 Bristol-Myers Squibb Company Company Information
        11.9.2 Bristol-Myers Squibb Company Rheumatology Therapeutics Product Offered
        11.9.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.9.4 Bristol-Myers Squibb Company Main Business Overview
        11.9.5 Bristol-Myers Squibb Company Latest Developments
    11.10 Merck & Co.
        11.10.1 Merck & Co. Company Information
        11.10.2 Merck & Co. Rheumatology Therapeutics Product Offered
        11.10.3 Merck & Co. Rheumatology Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
        11.10.4 Merck & Co. Main Business Overview
        11.10.5 Merck & Co. Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
    Table 1. Rheumatology Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
    Table 2. Major Players of Disease Modifying Anti-rheumatic Drugs
    Table 3. Major Players of Nonsteroidal Anti-inflammatory Drugs
    Table 4. Major Players of Corticosteroids
    Table 5. Major Players of Uric Acid Drugs
    Table 6. Major Players of Others
    Table 7. Rheumatology Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
    Table 8. Global Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
    Table 9. Global Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Table 10. Rheumatology Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
    Table 11. Global Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
    Table 12. Global Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Table 13. Global Rheumatology Therapeutics Revenue by Players (2019-2024) & ($ Millions)
    Table 14. Global Rheumatology Therapeutics Revenue Market Share by Player (2019-2024)
    Table 15. Rheumatology Therapeutics Key Players Head office and Products Offered
    Table 16. Rheumatology Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Rheumatology Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
    Table 20. Global Rheumatology Therapeutics Market Size Market Share by Regions (2019-2024)
    Table 21. Global Rheumatology Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
    Table 22. Global Rheumatology Therapeutics Revenue Market Share by Country/Region (2019-2024)
    Table 23. Americas Rheumatology Therapeutics Market Size by Country (2019-2024) & ($ Millions)
    Table 24. Americas Rheumatology Therapeutics Market Size Market Share by Country (2019-2024)
    Table 25. Americas Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
    Table 26. Americas Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Table 27. Americas Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
    Table 28. Americas Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Table 29. APAC Rheumatology Therapeutics Market Size by Region (2019-2024) & ($ Millions)
    Table 30. APAC Rheumatology Therapeutics Market Size Market Share by Region (2019-2024)
    Table 31. APAC Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
    Table 32. APAC Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Table 33. APAC Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
    Table 34. APAC Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Table 35. Europe Rheumatology Therapeutics Market Size by Country (2019-2024) & ($ Millions)
    Table 36. Europe Rheumatology Therapeutics Market Size Market Share by Country (2019-2024)
    Table 37. Europe Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
    Table 38. Europe Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Table 39. Europe Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
    Table 40. Europe Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Table 41. Middle East & Africa Rheumatology Therapeutics Market Size by Region (2019-2024) & ($ Millions)
    Table 42. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Region (2019-2024)
    Table 43. Middle East & Africa Rheumatology Therapeutics Market Size by Type (2019-2024) & ($ Millions)
    Table 44. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Table 45. Middle East & Africa Rheumatology Therapeutics Market Size by Application (2019-2024) & ($ Millions)
    Table 46. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Table 47. Key Market Drivers & Growth Opportunities of Rheumatology Therapeutics
    Table 48. Key Market Challenges & Risks of Rheumatology Therapeutics
    Table 49. Key Industry Trends of Rheumatology Therapeutics
    Table 50. Global Rheumatology Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
    Table 51. Global Rheumatology Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
    Table 52. Global Rheumatology Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
    Table 53. Global Rheumatology Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
    Table 54. Takeda Pharmaceutical Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 55. Takeda Pharmaceutical Rheumatology Therapeutics Product Offered
    Table 56. Takeda Pharmaceutical Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 57. Takeda Pharmaceutical Main Business
    Table 58. Takeda Pharmaceutical Latest Developments
    Table 59. Sanofi Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 60. Sanofi Rheumatology Therapeutics Product Offered
    Table 61. Sanofi Main Business
    Table 62. Sanofi Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 63. Sanofi Latest Developments
    Table 64. Genentech Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 65. Genentech Rheumatology Therapeutics Product Offered
    Table 66. Genentech Main Business
    Table 67. Genentech Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 68. Genentech Latest Developments
    Table 69. Novartis Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 70. Novartis Rheumatology Therapeutics Product Offered
    Table 71. Novartis Main Business
    Table 72. Novartis Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 73. Novartis Latest Developments
    Table 74. Janssen Biotech Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 75. Janssen Biotech Rheumatology Therapeutics Product Offered
    Table 76. Janssen Biotech Main Business
    Table 77. Janssen Biotech Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 78. Janssen Biotech Latest Developments
    Table 79. Amgen Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 80. Amgen Rheumatology Therapeutics Product Offered
    Table 81. Amgen Main Business
    Table 82. Amgen Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 83. Amgen Latest Developments
    Table 84. AbbVie Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 85. AbbVie Rheumatology Therapeutics Product Offered
    Table 86. AbbVie Main Business
    Table 87. AbbVie Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 88. AbbVie Latest Developments
    Table 89. Pfizer Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 90. Pfizer Rheumatology Therapeutics Product Offered
    Table 91. Pfizer Main Business
    Table 92. Pfizer Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 93. Pfizer Latest Developments
    Table 94. Bristol-Myers Squibb Company Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 95. Bristol-Myers Squibb Company Rheumatology Therapeutics Product Offered
    Table 96. Bristol-Myers Squibb Company Main Business
    Table 97. Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 98. Bristol-Myers Squibb Company Latest Developments
    Table 99. Merck & Co. Details, Company Type, Rheumatology Therapeutics Area Served and Its Competitors
    Table 100. Merck & Co. Rheumatology Therapeutics Product Offered
    Table 101. Merck & Co. Main Business
    Table 102. Merck & Co. Rheumatology Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
    Table 103. Merck & Co. Latest Developments
List of Figures
    Figure 1. Rheumatology Therapeutics Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Rheumatology Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
    Figure 6. Rheumatology Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
    Figure 7. Rheumatology Therapeutics Sales Market Share by Country/Region (2023)
    Figure 8. Rheumatology Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
    Figure 9. Global Rheumatology Therapeutics Market Size Market Share by Type in 2023
    Figure 10. Rheumatology Therapeutics in Hospital Pharmacy
    Figure 11. Global Rheumatology Therapeutics Market: Hospital Pharmacy (2019-2024) & ($ Millions)
    Figure 12. Rheumatology Therapeutics in Retail Pharmacy
    Figure 13. Global Rheumatology Therapeutics Market: Retail Pharmacy (2019-2024) & ($ Millions)
    Figure 14. Rheumatology Therapeutics in Online Pharmacy
    Figure 15. Global Rheumatology Therapeutics Market: Online Pharmacy (2019-2024) & ($ Millions)
    Figure 16. Global Rheumatology Therapeutics Market Size Market Share by Application in 2023
    Figure 17. Global Rheumatology Therapeutics Revenue Market Share by Player in 2023
    Figure 18. Global Rheumatology Therapeutics Market Size Market Share by Regions (2019-2024)
    Figure 19. Americas Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
    Figure 20. APAC Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
    Figure 21. Europe Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
    Figure 22. Middle East & Africa Rheumatology Therapeutics Market Size 2019-2024 ($ Millions)
    Figure 23. Americas Rheumatology Therapeutics Value Market Share by Country in 2023
    Figure 24. United States Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 25. Canada Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 26. Mexico Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 27. Brazil Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 28. APAC Rheumatology Therapeutics Market Size Market Share by Region in 2023
    Figure 29. APAC Rheumatology Therapeutics Market Size Market Share by Type in 2023
    Figure 30. APAC Rheumatology Therapeutics Market Size Market Share by Application in 2023
    Figure 31. China Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 32. Japan Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 33. Korea Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 34. Southeast Asia Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 35. India Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 36. Australia Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 37. Europe Rheumatology Therapeutics Market Size Market Share by Country in 2023
    Figure 38. Europe Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Figure 39. Europe Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Figure 40. Germany Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 41. France Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 42. UK Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 43. Italy Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 44. Russia Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 45. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Region (2019-2024)
    Figure 46. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Type (2019-2024)
    Figure 47. Middle East & Africa Rheumatology Therapeutics Market Size Market Share by Application (2019-2024)
    Figure 48. Egypt Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 49. South Africa Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 50. Israel Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 51. Turkey Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 52. GCC Country Rheumatology Therapeutics Market Size Growth 2019-2024 ($ Millions)
    Figure 53. Americas Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 54. APAC Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 55. Europe Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 56. Middle East & Africa Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 57. United States Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 58. Canada Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 59. Mexico Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 60. Brazil Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 61. China Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 62. Japan Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 63. Korea Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 64. Southeast Asia Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 65. India Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 66. Australia Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 67. Germany Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 68. France Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 69. UK Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 70. Italy Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 71. Russia Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 72. Spain Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 73. Egypt Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 74. South Africa Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 75. Israel Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 76. Turkey Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 77. GCC Countries Rheumatology Therapeutics Market Size 2025-2030 ($ Millions)
    Figure 78. Global Rheumatology Therapeutics Market Size Market Share Forecast by Type (2025-2030)
    Figure 79. Global Rheumatology Therapeutics Market Size Market Share Forecast by Application (2025-2030)

Companies Mentioned

Takeda Pharmaceutical

Sanofi

Genentech

Novartis

Janssen Biotech

Amgen

AbbVie

Pfizer

Bristol-Myers Squibb Company

Merck & Co.

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff